Clinical Trial

Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy.

Study acronym: RIGHT-GO
Recruiting
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to demonstrate that the growth of infants fed with the Test Formula is non-inferior those fed with the Control Formula. The study will also evaluate the gastrointestinal tolerance, quatliy of life and acceptability of the new rice protein-based formula in infants with cow's milk protein allergy (CMPA).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-07.
Status change: Not Yet Recruiting → Recruiting 2025-12-18
Trial Details
NCT Number NCT06633250
Lead Sponsor Société des Produits Nestlé (SPN)
Conditions Cow Milk Protein Allergy
Enrollment 104 participants
Start Date 2024-10-25
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-12-26